Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$949K Sell
8,847
-2,561
-22% -$234K 0.07% 266
2026
Q1
$1.04M Sell
11,408
-1,245
-10% -$141K 0.08% 240
2025
Q4
$1.56M Buy
12,653
+374
+3% +$47.6K 0.13% 173
2025
Q3
$1.53M Buy
12,279
+3,823
+45% +$502K 0.14% 167
2025
Q2
$1.13M Buy
8,456
+177
+2% +$23.3K 0.12% 190
2025
Q1
$1.08M Buy
8,279
+1,583
+24% +$201K 0.14% 160
2024
Q4
$757K Buy
+6,696
New +$774K 0.11% 190

Other funds holding ABT

Sovran Advisors's ABT Position: Q2 2026 in Review

Sovran Advisors reduced its Abbott (ABT) stake by 22% in Q2 2026, selling an estimated $234K and leaving 8,847 shares worth $949K. The position accounts for 0.07% of the portfolio, ranked #266.

Sovran Advisors first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.56M in Q4 2025. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Sovran Advisors held 8,847 shares of Abbott worth $949K as of Q2 2026.
  • Sovran Advisors sold 2,561 Abbott shares in Q2 2026, an estimated $234K.
  • Abbott made up 0.07% of Sovran Advisors's portfolio in Q2 2026, its #266 holding.
  • Sovran Advisors first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Sovran Advisors's Abbott position peaked at $1.56M in Q4 2025.
  • 2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.